KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) EBT Margin (2017 - 2025)

Historic EBT Margin for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to 18.41%.

  • Moderna's EBT Margin fell 195300.0% to 18.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 141.26%, marking a year-over-year decrease of 943500.0%. This contributed to the annual value of 111.46% for FY2024, which is 539000.0% down from last year.
  • Latest data reveals that Moderna reported EBT Margin of 18.41% as of Q3 2025, which was down 195300.0% from 576.06% recorded in Q2 2025.
  • Moderna's 5-year EBT Margin high stood at 75.02% for Q4 2021, and its period low was 892.59% during Q1 2025.
  • For the 5-year period, Moderna's EBT Margin averaged around 167.87%, with its median value being 1.13% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 16150500bps in 2021, then plummeted by -6812200bps in 2024.
  • Over the past 5 years, Moderna's EBT Margin (Quarter) stood at 75.02% in 2021, then tumbled by -57bps to 32.55% in 2022, then tumbled by -92bps to 2.49% in 2023, then plummeted by -5022bps to 122.57% in 2024, then soared by 85bps to 18.41% in 2025.
  • Its last three reported values are 18.41% in Q3 2025, 576.06% for Q2 2025, and 892.59% during Q1 2025.